跳至主要内容
临床试验/IRCT20081027001411N3
IRCT20081027001411N3招募中2 期

Study of Prednisolone effects on treatment and clinical symptoms and laboratory signs of Iranian COVID-19 patients: a clinical trial study

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • COVID-19 patient with Acute Respiratory Distress Syndrome (ARDS) and confirmed by positive PCR test for SARS-CoV-2
  • or confirmed by abnormal CT scan finding (bilateral, sub pleural, peripheral ground glass opacities),
  • With blood oxygen saturation <93%,
  • Not responding to stamdard COVID-19 treatment after 48-72h

排除标准

  • A history of type I diabetes, asthma and lung diseases, malignancies, kidney and heart failure, uncontrolled high blood pressure, positive pro-calcitonin and active infection
  • Taking immunosuppressive drugs and corticosteroids
  • Pregnant or lactating women
  • Prescribing antibiotics due to a bacterial infection

研究者

相似试验